SGLT2 Mediates Glucose-Induced Angiotensinogen Synthesis in Proximal Tubule Cells
SGLT2 介导近端小管细胞中葡萄糖诱导的血管紧张素原合成
基本信息
- 批准号:8983617
- 负责人:
- 金额:$ 4.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-04 至 2017-01-03
- 项目状态:已结题
- 来源:
- 关键词:AddressAngiotensin IIAngiotensinogenAntioxidantsAttenuatedBlood GlucoseBlood PressureCell Culture TechniquesCell LineCell membraneCellsChronicDevelopmentDiabetes MellitusDiabetic NephropathyExperimental DesignsGenerationsGlucoseHyperglycemiaHypertensionInjuryInsulin-Dependent Diabetes MellitusKidneyKidney FailureKnockout MiceLaboratoriesMeasuresMediatingMessenger RNAMitochondriaMolecularMusNADPH OxidaseNon-Insulin-Dependent Diabetes MellitusOxidative StressOxygen ConsumptionPathway interactionsPatientsPharmacologic SubstancePlasmaPreventionProcessProductionProteinsProximal Kidney TubulesReactive Oxygen SpeciesReceptor ActivationReceptor, Angiotensin, Type 1RegulationRenin-Angiotensin SystemReportingResearchRespirationRoleSodiumSourceStagingTestingTubular formationUnited StatesUp-RegulationUrineextracellularglucose metabolismhuman CYBA proteinimprovedinhibitor/antagonistinsightpreventpublic health relevancereceptorresponsesymportertempoltreatment strategy
项目摘要
DESCRIPTION (provided by applicant): The intra-renal renin-angiotensin system (RAS) has been implicated in the development of hypertension and the progression of kidney injury that results from diabetes mellitus. RAS blockade is an effective strategy in preventing diabetic nephropathy and hypertension during diabetes. The production of angiotensinogen (AGT) is upregulated in the renal proximal tubular cells under high glucose conditions. This process is partially mediated by the formation of reactive oxygen species (ROS) as a result of glucose metabolism and mitochondrial respiration. AGT forms angiotensin II (Ang II) which causes oxidative stress by activating the Ang II Type 1 Receptor (AT1R). AT1R activation is also a major source of ROS generation in proximal tubular cells. The overall aim of this proposal is to elucidate the mechanisms underlying the up-regulation of AGT in the proximal tubule during diabetes and chronic hyperglycemia. The sodium-glucose cotransporter 2 (SGLT2) is the primary mechanism responsible for reabsorbing filtered glucose in the kidney. It is not known if SGLT2- mediated glucose reabsorption is responsible for the increased intratubular AGT expression reported during diabetes. Therefore, our overall hypothesis is that the increase in AGT expression in proximal tubular cells under high glucose conditions is mediated by increased glucose entry via SGLT2 which synergizes with the effects of AT1R activation. This will provide insight into the molecular mechanisms that occur in the kidney in the early stages of diabetes. To test this hypothesis, we will establish an increase in ROS accumulation and AGT expression in proximal tubular cells cultured in high glucose conditions and that this upregulation is dependent on glucose entry via SGLT2. We will demonstrate that glucose entry and mitochondrial respiration are increased by Ang II through AT1R activation. In addition, we will show that AT1R activation synergizes with the effects of high glucose to augment AGT expression. The experimental design will utilize immortalized proximal tubular cell lines derived from the wild type and AT1R knockout mice. Canagliflozin, a highly selective pharmaceutical blocker of SGLT2, will be used to demonstrate the role of SGLT2 on the production of AGT during high glucose conditions and address the overall hypothesis.
描述(由申请方提供):肾内肾素-血管紧张素系统(RAS)与高血压的发生和糖尿病导致的肾损伤进展有关。RAS阻断是预防糖尿病肾病和糖尿病高血压的有效策略。在高糖条件下,肾近端小管细胞中血管紧张素原(AGT)的产生上调。这一过程部分由葡萄糖代谢和线粒体呼吸导致的活性氧(ROS)的形成介导。AGT形成血管紧张素II(Ang II),其通过激活Ang II 1型受体(AT 1 R)引起氧化应激。AT 1 R活化也是近端肾小管细胞中ROS产生的主要来源。本研究的总体目标是阐明糖尿病和慢性高血糖时近端小管AGT上调的机制。钠-葡萄糖协同转运蛋白2(SGLT 2)是肾脏重吸收滤过葡萄糖的主要机制。尚不清楚SGLT 2介导的葡萄糖重吸收是否是糖尿病期间报告的小管内AGT表达增加的原因。因此,我们的总体假设是,高糖条件下近端肾小管细胞中AGT表达的增加是通过SGLT 2增加葡萄糖进入介导的,SGLT 2与AT 1 R激活的作用协同作用。这将为深入了解糖尿病早期肾脏中发生的分子机制提供帮助。为了验证这一假设,我们将确定在高糖条件下培养的近端肾小管细胞中ROS蓄积和AGT表达增加,并且这种上调依赖于通过SGLT 2进入葡萄糖。我们将证明,葡萄糖进入和线粒体呼吸增加血管紧张素II通过AT 1 R激活。此外,我们将表明,AT 1 R激活协同作用的影响,高葡萄糖增加AGT的表达。实验设计将利用来源于野生型和AT 1 R敲除小鼠的永生化近端肾小管细胞系。卡格列净是一种高选择性的SGLT 2药物阻断剂,将用于证明高糖条件下SGLT 2对AGT产生的作用,并解决总体假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Winthers Cypress其他文献
Michael Winthers Cypress的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 4.31万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 4.31万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 4.31万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 4.31万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 4.31万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 4.31万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 4.31万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)